French artificial intelligence (AI) software developer Therapixel is collaborating with AI software developer Ferrum Health on providing a second read for breast cancer detection.
Therapixel's AI decision support for breast cancer screening is now available to Ferrum Health's U.S. customer base via the Ferrum Healthcare AI Hub. Ferrum Health customers are able to access MammoScreen and use it directly for concurrent reading decision support of screening mammograms. Customers can also use it with Ferrum Health's safety net program that offers a second reading service or assistance during the peer review of radiology studies.
